Grover P. Miller
- Pharmacology top 0.1%
- Pharmacogenetics and Drug Metabolism 56
- Drug-Induced Hepatotoxicity and Protection 9
- Inflammatory mediators and NSAID effects 9
-
- Computational Drug Discovery Methods 20
- Biochemistry top 2%
- Eicosanoids and Hypertension Pharmacology 16
- Molecular Biology top 5%
- Metabolomics and Mass Spectrometry Studies 11
- Toxicology top 5%
-
- Drug Transport and Resistance Mechanisms 12
-
- Analytical Chemistry and Chromatography 11
Grover P. Miller
96 papers receiving 2.7k citations
Peers
Comparison fields: 5 of 132
- Pharmacology 1.1k
- Computational Theory and Mathematics 466
- Biochemistry 199
- Molecular Biology 1.3k
- Toxicology 60
Countries citing papers authored by Grover P. Miller
This map shows the geographic impact of Grover P. Miller's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Grover P. Miller with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Grover P. Miller more than expected).
Fields of papers citing papers by Grover P. Miller
This network shows the impact of papers produced by Grover P. Miller. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Grover P. Miller. The network helps show where Grover P. Miller may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Grover P. Miller, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2023 | 8 | |
| 3 | 2022 | 1 | |
| 4 | 2021 | 6 | |
| 5 | 2021 | 28 | |
| 6 | 2020 | 14 | |
| 7 | 2020 | 8 | |
| 8 | 2020 | 16 | |
| 9 | 2017 | 9 | |
| 10 | 2014 | 8 | |
| 11 | 2013 | 40 | |
| 12 | 2013 | 4 | |
| 13 | Novel multi-mode ultra performance liquid chromatography–tandem mass spectrometry assay for profiling enantiomeric hydroxywarfarins and warfarin in human plasma | 2011 | 1 |
| 14 | 2011 | 38 | |
| 15 | 2010 | 25 | |
| 16 | 2010 | 14 | |
| 17 | 2010 | 19 | |
| 18 | 2008 | 12 | |
| 19 | 2007 | 32 | |
| 20 | 1997 | 6 |
About Grover P. Miller
Grover P. Miller is a scholar working on Pharmacology, Biochemistry and Computational Theory and Mathematics, having authored 97 papers that have together received 2.8k indexed citations. Recurring topics across this work include Pharmacogenetics and Drug Metabolism (56 papers), Computational Drug Discovery Methods (20 papers), Eicosanoids and Hypertension Pharmacology (16 papers), Drug Transport and Resistance Mechanisms (12 papers), Metabolomics and Mass Spectrometry Studies (11 papers), Analytical Chemistry and Chromatography (11 papers), Drug-Induced Hepatotoxicity and Protection (9 papers) and Inflammatory mediators and NSAID effects (9 papers). The work is most often cited by research in Pharmacology (1.1k citations), Computational Theory and Mathematics (466 citations) and Biochemistry (199 citations). Grover P. Miller has collaborated with scholars based in United States, Netherlands and South Korea. Frequent co-authors include F. Peter Guengerich, S. Joshua Swamidass, Tyler B. Hughes, Eric T. Kool, Natilie Hosea, Stephen J. Benkovic, Chul‐Ho Yun, Jessica H. Hartman, Drew R. Jones and Stephen J. Benkovic.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.